Author

Jacky Gomez-Villa

University of Chicago

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1

Frequent Co-Authors

Natalia L. Antonides-Jensen· 2 shared Samantha S YeeiD· 2 shared Sonia L. HernandeziD· 2 shared Fernando Flores-GuzmániD· 1 shared John C. AlverdyiD· 1 shared Kenneth B. BaderiD· 1 shared Lavanya VisvabharathyiD· 1 shared Lydia L. WuiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Natalia L. Antonides-Jensen

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Histotripsy-initiated immune response synergizes with chemotherapy in a neuroblastoma murine model

Natalia L. Antonides-Jensen, Muskan Singh, Yuqing Xue, Fernando Flores-Guzmán, Lydia L. Wu, Samantha S Yee, Jacky Gomez-Villa, Timothy L. Hall, Mark A. Applebaum, Kenneth B. Bader, Sonia L. Hernandez

This study shows histotripsy enhances chemotherapy effectiveness in a neuroblastoma mouse model by inducing a systemic immune response and altering the tumor microenvironment.

Cancers · Apr 15, 2026Peer-reviewedCancer Biology

IL-6R blockade with tocilizumab disrupts pericyte-and tumor cell-driven IL-6/STAT3 signaling, enhancing docetaxel efficacy in ER+ breast cancer

Róża K. Przanowska, Jacky Gomez-Villa, Victoria J. Liu, Natalia L. Antonides-Jensen, Lavanya Visvabharathy, John C. Alverdy, Sonia L. Hernandez, Samantha S Yee

This study shows that tocilizumab enhances docetaxel efficacy in ER+ breast cancer by blocking IL-6/STAT3 signaling driven by pericytes and tumor cells.

bioRxiv · Jan 30, 2026 · PreprintCancer Biology